content=["<dl>",
"<dt><a href='#Section0'>Drug rash</a></dt>",
"<dd id='Section0'>",
"<p><strong>Sign & Symptoms:</strong> Rash may coincide with the timing of recent initiation of antibiotics or following a recent course of chemotherapy or radiation therapy.",
"<br><strong>Test:</strong> Skin biopsy: if the rash does not improve with removing the offending drug, skin biopsy may reveal infiltration of eosinophilic polymorphonuclear leukocytes suggestive of a drug-induced lesion.</p>",
"</dd>",
"<dt><a href='#Section1'>Radiation rash</a></dt>",
"<dd id='Section1'>",
"<p><strong>Sign & Symptoms:</strong> Rash may coincide with the timing of recent radiation therapy.",
"<br><strong>Test:</strong> Clinical diagnosis. No differentiating tests.</p>",
"</dd>",
"<dt><a href='#Section2'>Bacterial gastroenteritis</a></dt>",
"<dd id='Section2'>",
"<p><strong>Sign & Symptoms:</strong> Contaminated food or water. Travel to developing country.",
"<br><strong>Test:</strong> Stool cultures are recommended in order to rule out an infectious cause for the enteritis symptoms that may mimic GI graft-versus-host disease (GVHD).</p>",
"</dd>",
"<dt><a href='#Section3'>Viral gastroenteritis</a></dt>",
"<dd id='Section3'>",
"<p><strong>Sign & Symptoms:</strong> Known infectious contact, or foodborne or waterborne epidemic outbreak.",
"<br><strong>Test:</strong> Stool rapid antigen testing: may detect rotavirus or calicivirus.Stool reverse transcriptase PCR: may detect rotavirus, norovirus, astrovirus, or adenovirus.Stool viral culture and electron microscopy: may detect and identify viral cause.</p>",
"</dd>",
"<dt><a href='#Section4'>Neutropenic colitis</a></dt>",
"<dd id='Section4'>",
"<p><strong>Sign & Symptoms:</strong> Clinically indistinguishable from GVHD.",
"<br><strong>Test:</strong> Abdominal x-ray or abdominal CT scan: may reveal thickening of the colon with fat stranding (an appearance of stranding in peritoneal fat due to inflammation).</p>",
"</dd>",
"<dt><a href='#Section5'>Pseudomembranous colitis</a></dt>",
"<dd id='Section5'>",
"<p><strong>Sign & Symptoms:</strong> Recent antibiotic use.",
"<br><strong>Test:</strong> Stool testing for Clostridium difficile is the first-line diagnostic approach. If this test is negative, colonoscopy or sigmoidoscopy may be warranted.</p>",
"</dd>",
"<dt><a href='#Section6'>Crohn's disease</a></dt>",
"<dd id='Section6'>",
"<p><strong>Sign & Symptoms:</strong> Weight loss, perianal lesions such as skin tags, ulcerations, and fistulae.",
"<br><strong>Test:</strong> Colonoscopy: aphthous ulcers, hyperaemia, oedema, cobblestoning, and skip lesions in Crohn's disease.</p>",
"</dd>",
"<dt><a href='#Section7'>Ulcerative colitis</a></dt>",
"<dd id='Section7'>",
"<p><strong>Sign & Symptoms:</strong> Extraintestinal manifestations such as arthritis, spondylitis, erythema nodosum, pyoderma gangrenosum, uveitis, and episcleritis.",
"<br><strong>Test:</strong> Colonoscopy: rectal involvement, continuous uniform involvement, loss of vascular marking, diffuse erythema, mucosal granularity, fistulas (rarely seen), and normal terminal ileum (or mild backwash ileitis in pancolitis) in ulcerative colitis.</p>",
"</dd>",
"<dt><a href='#Section8'>Drug-induced enteritis</a></dt>",
"<dd id='Section8'>",
"<p><strong>Sign & Symptoms:</strong> Enteritis may coincide with introduction of new medications.",
"<br><strong>Test:</strong> Trial drug withdrawal: discontinuation or lowering the dosages of medications known to affect the GI tract may lead to improvement or resolution of abdominal symptoms.</p>",
"</dd>",
"<dt><a href='#Section9'>Drug-induced hepatoxicity</a></dt>",
"<dd id='Section9'>",
"<p><strong>Sign & Symptoms:</strong> Medication history includes drugs with known hepatotoxicity.May include pruritus, arthralgia, headache, and anorexia.",
"<br><strong>Test:</strong> Elevation of liver function tests, including bilirubin, ALT, AST, or alkaline phosphatase.Trial drug withdrawal: discontinuation or lowering the dosages of medications known to be hepatotoxic may lead to improvement or resolution of liver function abnormalities.</p>",
"</dd>",
"<dt><a href='#Section10'>Viral hepatitis</a></dt>",
"<dd id='Section10'>",
"<p><strong>Sign & Symptoms:</strong> Positive for risk factors (e.g., blood transfusion, intravenous drug use, overseas travel).May be recent exposure to infected individuals.",
"<br><strong>Test:</strong> Polymerase chain reaction (PCR) blood tests for viral studies: may detect human herpes virus-6, cytomegalovirus, Epstein-Barr virus, adenovirus, hepatitis B, and hepatitis C.</p>",
"</dd>",
"<dt><a href='#Section11'>Veno-occlusive disease (VOD)</a></dt>",
"<dd id='Section11'>",
"<p><strong>Sign & Symptoms:</strong> Hepatomegaly usually present, RUQ pain, and ascites is the classic triad for VOD.",
"<br><strong>Test:</strong> Liver Doppler ultrasound: shows increased phasicity of portal veins with eventual development of portal flow reversal. The liver is usually enlarged but maintains normal echogenicity.Liver biopsy: required for a definitive diagnosis.</p>",
"</dd>",
"<dt><a href='#Section12'>Total parenteral nutrition (TPN) associated cholestasis</a></dt>",
"<dd id='Section12'>",
"<p><strong>Sign & Symptoms:</strong> Current treatment with TPN.Pale stools and/or dark urine are non-specific findings with cholestasis. Anorexia and decreased appetite may also be present.",
"<br><strong>Test:</strong> Abdominal ultrasound: may reveal gallbladder sludge with mild thickening.Liver function tests: may show elevated AST, ALT, bilirubin, and alkaline phosphatase.Serum triglycerides and cholesterol may also be elevated.Trial withdrawal of TPN may lead to improvement of liver function abnormalities.</p>",
"</dd>",
"<dt><a href='#Section13'>Acalculous cholecystitis</a></dt>",
"<dd id='Section13'>",
"<p><strong>Sign & Symptoms:</strong> Pain often localised to RUQ or jaundice may be presenting signs for acute or chronic cholecystitis.",
"<br><strong>Test:</strong> Liver function tests: may show elevated AST, ALT, bilirubin, and alkaline phosphatase.Abdominal ultrasound: echogenic sludge within a moderately distended gallbladder. No discrete gallstones. The gallbladder wall is not thickened. No biliary ductal dilation.Abdominal CT scan: no gallstones seen. Sludge may be present.Hepatobiliary scintigraphy: highly sensitive (95%) and specific (99%) for diagnosing acute cholecystitis. Serial images show normal hepatic uptake of radiotracer with normal visualisation of common duct and bowel at 30 minutes after injection. The gallbladder is not visualised at 1 hour despite an intravenously administered dose of morphine sulphate.</p>",
"</dd>",
"<dt><a href='#Section14'>Polypharmacy and drug interactions</a></dt>",
"<dd id='Section14'>",
"<p><strong>Sign & Symptoms:</strong> No distinguishing signs or symptoms.",
"<br><strong>Test:</strong> Discontinuation or holding of suspect medication(s) may result in improvement in symptoms.</p>",
"</dd>",
"</dl>"].join("\n");